Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan - 2012 Version

被引：330

作者：

Teramoto, Tamio ^{[1
,2
,3
,4
,5
,6
,7
,8
,9
]}

Sasaki, Jun ^{[4
,6
]}

Ishibashi, Shun ^{[2
,10
]}

Birou, Sadatoshi

Daida, Hiroyuki ^{[1
,2
,4
,5
,6
,10
,11
,12
,13
,14
,15
,16
,17
,18
]}

Dohi, Seitaro

Egusa, Genshi

Hiro, Takafumi ^{[2
]}

Hirobe, Kazuhiko

Iida, Mami

Kihara, Shinji

Kinoshita, Makoto ^{[4
]}

Maruyama, Chizuko

Ohta, Takao

Okamura, Tomonori

Yamashita, Shizuya ^{[2
,6
,9
,19
,20
,21
,26
]}

Yokode, Masayuki ^{[20
]}

Yokote, Koutaro ^{[2
,4
,5
,9
,10
,16
,17
,18
,22
,23
,24
,25
,26
]}

机构：

[1] Astellas Pharma Inc, Tsukuba, Ibaraki, Japan

[2] Kowa Pharmaceut Co Ltd, Higashimurayama, Japan

[3] Kissei Pharmaceut Co Ltd, Azumino City, Nagano, Japan

[4] Daiichi Sankyo Co Ltd, Hiratsuka, Kanagawa, Japan

[5] Pfizer Co Ltd, Kirtland, PQ, Canada

[6] Bayer Yakuhin Ltd, Kouga City, Shiga, Japan

[7] Kobayashi Pharmaceut Co Ltd, Osaka, Japan

[8] GlaxoSmithKline KK, Tokyo, Japan

[9] Shionogi & Co Ltd, Toyonaka, Osaka, Japan

[10] Takeda Pharmaceut Co Ltd, Osaka, Japan

[11] AstraZeneca KK, Osaka, Japan

[12] Mochida Pharmaceut Co Ltd, Tokyo, Japan

[13] Nippon Boehringer Ingelheim Co Ltd, Saitama, Japan

[14] Boston Sci Japan KK, Miyazaki, Japan

[15] Mitsubishi Tanabe Pharma Corp, Saitama, Japan

[16] Dainippon Sumitomo Pharma Co Ltd, Niihama, Ehime, Japan

[17] Sanofi Aventis KK, Tokyo, Japan

[18] Novartis Pharma KK, Tokyo, Japan

[19] Skylight Biotech Inc, Akita, Japan

[20] Otsuka Pharmaceut Co Ltd, Tokyo, Japan

[21] Kissei Pharmaceut Co Ltd, Azumino City, Nagano, Japan

[22] Ono Pharmaceut Co Ltd, Osaka, Japan

[23] Eli Lilly Japan KK, Kobe, Hyogo, Japan

[24] Novo Nordisk Pharma Ltd, Tokyo, Japan

[25] Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan

[26] Astellas Pharma Inc, Tsukuba, Ibaraki, Japan

来源：

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 2013年 / 20卷 / 06期

关键词：

D O I：

10.5551/jat.15792

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：517 / 523

页数：7

共 13 条

[1] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[2] Morbidity of myocardial infarction multicenter study in Japan (3M study) - Study design and event rates for myocardial infarction and coronary death by age category in Japanese workers [J].

Hirobe, K ;

Terai, T ;

Fujioka, S ;

Goto, K ;

Dohi, S .

CIRCULATION JOURNAL, 2005, 69 (07) :767-773

[3] Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: The Circulatory Risk in Communities Study (CIRCS) [J].

Imano, Hironori ;

Noda, Hiroyuki ;

Kitamura, Akihiko ;

Sato, Shinichi ;

Kiyama, Masahiko ;

Sankai, Tomoko ;

Ohira, Tetsuya ;

Nakamura, Masakazu ;

Yamagishi, Kazumasa ;

Ikeda, Ai ;

Shimamoto, Takashi ;

Iso, Hiroyasu .

PREVENTIVE MEDICINE, 2011, 52 (05) :381-386

[4] HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND PREMATURE CORONARY HEART-DISEASE IN URBAN JAPANESE MEN [J].

KITAMURA, A ;

ISO, H ;

NAITO, Y ;

IIDA, M ;

KONISHI, M ;

FOLSOM, AR ;

SATO, S ;

KIYAMA, M ;

NAKAMURA, M ;

SANKAI, T ;

SHIMAMOTO, T ;

KOMACHI, Y .

CIRCULATION, 1994, 89 (06) :2533-2539

[5] Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease - Secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT) [J].

Mabuchi, H ;

Kita, T ;

Matsuzaki, M ;

Matsuzawa, Y ;

Nakaya, N ;

Oikawa, S ;

Saito, Y ;

Sasaki, J ;

Shimamoto, K ;

Itakura, H .

CIRCULATION JOURNAL, 2002, 66 (12) :1096-1100

[6] Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with Hypercholesterolemia - Primary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT) [J].

Matsuzaki, M ;

Kita, T ;

Mabuchi, H ;

Matsuzawa, Y ;

Nakaya, N ;

Oikawa, S ;

Saito, Y ;

Sasaki, J ;

Shimamoto, K ;

Itakura, H .

CIRCULATION JOURNAL, 2002, 66 (12) :1087-1095

[7]

Menotti A, 1997, EUR HEART J, V18, P566

[8] The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort [J].

Okamura, Tomonori ;

Tanaka, Hideo ;

Miyamatsu, Naomi ;

Hayakawa, Takehito ;

Kadowaki, Takashi ;

Kita, Yoshikuni ;

Nakamura, Yasuyuki ;

Okayama, Akira ;

Ueshima, Hirotsugu .

ATHEROSCLEROSIS, 2007, 190 (01) :216-223

[9]

Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1016/j.atherosclerosis.2011.06.012, 10.1093/eurheartj/ehr158]

[10] Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA [J].

Saito, I ;

Folsom, AR ;

Aono, H ;

Ozawa, H ;

Ikebe, T ;

Yamashita, T .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2000, 29 (05) :837-844

← 1 2 →